What is the Org number of Xvivo Perfusion Aktiebolag?

Xvivo Perfusion Aktiebolag is registered with Bolagsverket / SCB under Org 5565610424.

What is the revenue of Xvivo Perfusion Aktiebolag?

Xvivo Perfusion Aktiebolag reported revenue of SEK 453,1M in 2024.

Lena Birgitta Hagman is Chief Executive Officer of Xvivo Perfusion Aktiebolag, in role since 2024.

Per Gösta Johannesson chairs the board of Xvivo Perfusion Aktiebolag, in role since 2020.

Xvivo Perfusion Aktiebolag's registered address is Entreprenörsstråket 10.

ABActive

Org 5565610424Entreprenörsstråket 10, 431 53 MölndalResearch and experimental development on natural sciences and engineering · NACE 7210Est. 199850-99 employees

Actively employed in the business

Name	Role	Member since
Current (3)
LB Lena Birgitta Hagman Chief Executive Officer	Chief Executive Officer	2024
CB Christoffer Björn Rosenblad Chief Executive Officer	Chief Executive Officer	2020
JD Johan Daniel Haglund Chief Auditor	Chief Auditor	2022
Former (3)
DO Dag Olov Andersson Tilk Chief Executive Officer	Chief Executive Officer	2020 – 2022
JO Jan Olof Malm Chief Auditor	Chief Auditor	2020 – 2020
MH Magnus Henrik Ludvig Nilsson Chief Executive Officer	Chief Executive Officer	2020 – 2020

Non-executive oversight

Name	Role	Member since
Current (9)
PR Paul Robert Marcun	Board of Directors	2025
LE Lars Erik Henriksson	Board of Directors	2020
EA Emil Anders Billbäck	Board of Directors	2026
LM Lena Marie Höglund	Board of Directors	2022
PG Per Gösta Johannesson	Chairman	2020
AH Anne-Karen Hunt	Board of Directors	2026
EC Eva Camilla Öberg	Board of Directors	2020
NG Nils Göran Dellgren	Board of Directors	2022
EA Erik Anders Strömqvist	Board of Directors	2022
Former (3)
YC Yvonne Christine Mårtensson	Board of Directors	2022 – 2023
NN Nils-Folke Nilsson	Board of Directors	2020 – 2022
AH Alan Henry Raffensperger	Board of Directors	2020 – 2020

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.